Cite
Gupta G, Lee CD, Guye ML, et al. Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer. Ann Breast Cancer Ther. 2020;4(1):48-57doi: 10.36959/739/525.
Gupta, G., Lee, C. D., Guye, M. L., Van Sciver, R. E., Lee, M. P., Lafever, A. C., Pang, A., Tang-Tan, A. M., Winston, J. S., Samli, B., Jansen, R. J., Hoefer, R. A., & Tang, A. H. (2020). Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer. Annals of breast cancer and therapy, 4(1), 48-57. https://doi.org/10.36959/739/525
Gupta, Gagan, et al. "Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer." Annals of breast cancer and therapy vol. 4,1 (2020): 48-57. doi: https://doi.org/10.36959/739/525
Gupta G, Lee CD, Guye ML, Van Sciver RE, Lee MP, Lafever AC, Pang A, Tang-Tan AM, Winston JS, Samli B, Jansen RJ, Hoefer RA, Tang AH. Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer. Ann Breast Cancer Ther. 2020 May 02;4(1):48-57. doi: 10.36959/739/525. PMID: 32542231; PMCID: PMC7295150.
Copy
Download .nbib